| Literature DB >> 31765834 |
Pinelopi Arvaniti1, Christelle Le Dantec2, Amandine Charras3, Marina A Arleevskaya4, Christian M Hedrich5, Kalliopi Zachou6, George N Dalekos7, Yves Renaudineau8.
Abstract
DNA methylation represents an important regulatory event governing gene expression that is dysregulated in Sjögren's syndrome (SjS) and a number of autoimmune/inflammatory diseases. As disease-associated single-nucleotide polymorphisms (SNPs) have relevance in controlling DNA methylation, 94 non-HLA SjS-SNPs were investigated, among them 57 (60.6%) with widespread effects on 197 individual DNA methylation quantitative trait loci (meQTL) were selected. Typically, these SNPs are intronic, possess an active promoter histone mark, and control cis-meQTLs located around transcription start sites. Interplay is independent of the physical distance between SNPs and meQTLs. Using epigenome-wide association study datasets, SjS-meQTLs were characterized (41 genes and 13 DNA methylation CpG motifs) and for the most part map to a pro-inflammatory cytokine pathway, which is important for the control of DNA methylation in autoimmune diseases. In conclusion, exploring meQTLs represents a valuable tool to predict and investigate downstream effects of genetic factors in complex diseases such as SjS. CrownEntities:
Keywords: Pro-inflammatory cytokine pathway; SNP; Sjögren's syndrome; meQTL
Mesh:
Substances:
Year: 2019 PMID: 31765834 DOI: 10.1016/j.clim.2019.108314
Source DB: PubMed Journal: Clin Immunol ISSN: 1521-6616 Impact factor: 3.969